Evidence map›Paper›PMID 37989955›Full record

ArticleAnnals of surgical oncology2024

Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer.

Takashi Kanemura, Tomohira Takeoka, Takahito Sugase, Shinya Urakawa, Yasunori Masuike, Naoki Shinno, Hisashi Hara, Masatoshi Kitakaze, Masahiko Kubo, Yousuke Mukai and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2026
    Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Takashi KanemuraDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Tomohira TakeokaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Takahito SugaseDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Shinya UrakawaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Yasunori MasuikeDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Naoki ShinnoDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Hisashi HaraDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Masatoshi KitakazeDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Masahiko KuboDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Yousuke MukaiDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Toshinori SuedaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Shinichiro HasegawaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Hirofumi AkitaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Junichi NishimuraDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Hiroshi WadaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Masayoshi YasuiDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Takeshi OmoriDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Hiroshi MiyataDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan. miyata-hi@mc.pref.osaka.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe assessment of muscle mass loss, muscle strength, and physical function has been recommended in diagnosing sarcopenia. However, only muscle mass has been assessed in previous studies. Therefore, this study investigated the effect of comprehensively diagnosed preoperative sarcopenia on the prognosis of patients with esophageal cancer.

methodsThe study analyzed 115 patients with esophageal cancer (age ≥ 65 years) who underwent curative esophagectomy. Preoperative sarcopenia was analyzed using the skeletal mass index (SMI), handgrip strength, and gait speed based on the Asian Working Group for Sarcopenia 2019 criteria. Clinicopathologic factors, incidence of postoperative complications, and overall survival (OS) were compared between the sarcopenia and non-sarcopenia groups. The significance of the three individual parameters also was evaluated.

resultsThe evaluation identified 47 (40.9%) patients with low SMI, 31 (27.0%) patients with low handgrip strength, and 6 (5.2%) patients with slow gait speed. Sarcopenia was diagnosed in 23 patients (20%) and associated with older age and advanced pT stage. The incidence of postoperative complications did not differ significantly between the two groups. Among the three parameters, only slow gait speed was associated with Clavien-Dindo grade 2 or greater complications. The sarcopenia group showed significantly worse OS than the non-sarcopenia group. Those with low handgrip strength tended to have worse OS, and those with slow gait speed had significantly worse OS than their counterparts.

conclusionsPreoperative sarcopenia diagnosed using skeletal muscle mass, muscle strength, and physical function may have an impact on the survival of patients with esophageal cancer.

Indexed as

Esophageal NeoplasmsSarcopeniaAgedHand StrengthHumansMusclesMuscle, SkeletalMuscle StrengthPostoperative ComplicationsPrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.